IBM (IBM) unveiled a new Watson Health business unit with several big-name partners and two small acquisitions, as it expands the health-care uses for its artificial intelligence computer. The IT giant said Monday that it will work with Apple (AAPL), Johnson & Johnson (JNJ) and Medtronic (MDT) to “help optimize consumer and medical devices for data collection, analysis and feedback.” IBM also announced that it bought Explorys and Phtyel, two
Medical-device giant Medtronic (MDT) early Tuesday delivered a solid quarter and modestly bullish revenue guidance as it digests several small acquisitions and prepares for a huge one. Medtronic was up 3.5% in early trading in the stock market today, near 71.50. Earlier, Medtronic stock rose as high as 72.26, touching an all-time high for the fifth time in the past 10 trading days. Medtronic’s earnings for its fiscal Q2 ended Oct. 24 totaled 96
Medtronic’s $43 billion buyout of fellow medical-device giant Covidien got a mostly friendly reception on Wall Street Monday, as some analysts foresaw a further round of mega-mergers amid a changing industry landscape. Late Sunday, Medtronic (MDT) announced it had agreed to buy Covidien (COV) in a cash-and-stock deal that would give Covidien shareholders 30% ownership of the new company. The deal would relocate Medtronics’ corporate headquarters